Table 1.
Clinical parameters of the study patients at urine collection.
| Group, Sample | Age | Gender | DM | HT | Crea. | Prot. | Months from RT | LD | Donor Age |
|---|---|---|---|---|---|---|---|---|---|
| N1 | 64 | F | − | − | 0.86 | 99 | 137.9 | − | 53 |
| N2 | 65 | M | − | + | 0.86 | 110 | 186.6 | − | 37 |
| N3 | 45 | F | − | + | 0.82 | 30 | 113.6 | − | 43 |
| N4 | 42 | M | − | + | 0.89 | 187 | 186.6 | − | 30 |
| N5 | 57 | M | − | + | 0.9 | 92 | 166.4 | − | 45 |
| N6 | 65 | F | − | − | 0.85 | 55 | 70.0 | + | 37 |
| N7 | 69 | F | − | + | 1.14 | 86 | 57.8 | + | 58 |
| C8 | 55 | M | + | + | 2.29 | 506 | 0.5 | + | 62 |
| C9 | 33 | M | − | − | 1.93 | 232 | 2.8 | + | 59 |
| C10 | 49 | F | − | + | 3.08 | 427 | 238.8 | − | 45 |
| C11 | 50 | F | − | − | 2.49 | 207 | 5.5 | − | 60 |
| C12 | 41 | F | − | + | 1.80 | 76 | 25.7 | − | 34 |
| I13 | 50 | F | − | − | 2.00 | 62 | 21.7 | + | 48 |
| I14 | 64 | M | − | + | 1.60 | 1600 | 84.6 | − | 71 |
| I15 | 68 | M | − | + | 2.49 | 94 | 25.8 | − | 67 |
| I16 | 68 | M | + | + | 2.62 | 800 | 15.1 | − | 38 |
| I17 | 53 | F | − | + | 2.30 | 806 | 252.3 | − | 35 |
| Sig. | ns | ns | ns | ns | *** | ns | ns | ns | ns |
| p-value | 0.064 a | 0.784 b | 0.452 b | 0.784 b | <0.001 a | 0.093 a | 0.113 a | 0.784 b | 0.387 a |
a Kruskall–Wallis test or b Chi-squared test were performed to determine statistical differences between groups. N, NKF, C, CNIT; I, IFTA; DM, diabetes mellitus type 2; HT, arterial hypertension; Crea., serum creatinine (mg/dL); Prot., proteinuria (mg/g creatinine); Months from RT., months from renal transplantation until sample collection; LD, living donor; F, female; M, male.